Locations:
Search IconSearch

Cancer

22-NEU-3367462-T-cells-650×450
December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

whipple procedure
November 30, 2022/Cancer

Case Study: Patient Undergoing Whipple After Liver Transplant

Atypical cells discovered after primary sclerosing cholangitis diagnosis

influenza
November 28, 2022/Cancer

Infectious Disease Protections for Patients with Cancer

A Q&A with infectious disease expert Eric Cober, MD

Dr. Shoemaker
November 23, 2022/Cancer

Demystifying Palliative Care

Integral support for living well with cancer

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

breast cancer radiation
November 3, 2022/Cancer/Research

High Rates of Breast Cancer Recurrence after Intraoperative Radiation Therapy

Research supports national guidelines for early-stage breast cancer

22-DDI-3150240 Complete mesocolic excision for colon cancer 650×450
November 2, 2022/Cancer

The Case for Complete Mesocolic Excision

Outcome supports procedure’s routine use in colon cancer surgery

melanoma
November 2, 2022/Cancer/Research

Questions Remain about When to Employ Immunotherapy for Resected High-Risk Melanoma

Timing of adjuvant immunotherapy unclear for maximum overall survival

22-CNR-3290514-CQD-Hero-650×450 lung cancer
October 27, 2022/Cancer/Research

Higher-dose Stereotactic Radiotherapy Achieves Better Control for Many Aggressive Lung Tumors

Treatment decision must be balanced against toxicity concerns

22-CNR-3290543-CQD-Hero-650×450 throat cancer
October 26, 2022/Cancer/Research

Predicting Overall Survival in HPV-Positive Oropharyngeal Squamous Cell Carcinoma

Genomic adjusted radiation dose guides treatment decision making

BackPage 33 of 88Next

Advertisement

Ad